Pro
Healthcare-focused private equity firm InvAscent is looking to partially exit its three-year-old investment in a South India-based manufacturer of bulk drugs as the company gears up for an initial public offering, two people familiar with the matter told VCCircle. InvAscent, which crossed the halfway mark for its fourth fund in June ......